PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

about

PPARA intron polymorphism associated with power performance in 30-s anaerobic Wingate Test.Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Pharmacogenomic testing and antithrombotic therapy: ready for prime time?

P2860

Q34149893-6ADFABE8-DDB8-49C9-B10A-57BCCFCD5557 Q35569436-070F463C-152F-40E4-B402-19423C5364CC Q36919495-8561C75C-EA2A-45FF-9436-FD7EE779AE56

P2860

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

Item

http://www.wikidata.org/entity/Q36528512

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@ast

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@en

type

Item

label

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@ast

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@en

prefLabel

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@ast

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

@en

P1476

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease

@en

P2093

Sharon Cresci

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

PPAR delta: an uncompletely known nuclear receptor

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR

PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro

Peroxisome proliferator-activated receptors, coactivators, and downstream targets

The organization, promoter analysis, and expression of the human PPARgamma gene

P304

374549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/374549

http://www.w3.org/2001/XMLSchema#string

P478

2008

http://www.w3.org/2001/XMLSchema#string

P50

Sharon Cresci

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5452165

http://www.w3.org/2001/XMLSchema#string

P698

18401448

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

2288645

http://www.w3.org/2001/XMLSchema#string

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

about

P2860

P2860

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932